We discussed that for many people, the most powerful tools for medical weight management are the glucagon like peptide 1 (GLP1) agonists.
As of 2024, insurance, not body weight or BMI, has become the most important vital sign for doctors who see patients for medical weight management.
They really did transform a fairly barren landscape of pharmacotherapeutic options for medical weight management that lasted several decades.
Weight loss is on average about 15% with Wegovy and 22% with Zepbound, with super responders losing more than 25% of their body weight.
By comparison, other medications that are FDA-approved for weight loss, including Qsymia and Contrave, are combinations of much older drugs.
Persons:
Jody Dushay, MMSc, Beth, I’ve, Stanley, —, cravings
Organizations:
Medicine, Harvard Medical School, Beth Israel Deaconess Medical, CNN, Insurance, FDA, Medicare
Locations:
Boston, prediabetes